In the third part of the continuing series on the broader topic of Fostering Life Science Innovation, we zoom in on the important concept of transitioning technologies from the university lab to the next stage of...
Enhance Diagnostics, a clinical-stage company focused on non-invasive diagnostic solutions announced today a key leadership transition. Dr. Matthew Leming, PhD, formerly Chief Scientific Officer, has been appointed...
DALLAS, Oct. 21, 2025 -- Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today announced the successful, FDA-authorized compassionate use of its...
The VIC Fellows Program offers experienced professionals the opportunity to learn how to identify and evaluate high-potential innovations from around the world. We’re proud to showcase the members of the 2025–2026...
Investing in life sciences is both challenging and rewarding. The sector demands significant capital, long timelines, and careful diligence, but it also offers the chance to back breakthroughs that improve and save...
VIC Tech is pleased to announce the appointment of Alex Cameron to its Strategic Advisory Board (SAB). Alex is a globally experienced life sciences executive with a proven track record of launching innovative products,...
Cellia Science a biotechnology company advancing rapid, cell-based diagnostic technologies, announced today that it has been awarded a $306,872 Small Business Innovation Research (SBIR) Phase I grant from the National...
Enhance Diagnostics, announced today that it has been awarded a $307,000 Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Child Health and Human Development (NICHD), part of the...
VIC Tech, a venture studio building life science companies from university and federal lab innovations, announced today the appointment of Dr. Jeff White to its Strategic Advisory Board (SAB). A seasoned life science...
The life sciences industry has always been shaped by waves of disruption, but in 2025 the turbulence feels more structural than cyclical. Early-stage companies and their investors now find themselves facing delayed...
FEATURED RESOURCES
